Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
Cytokinetics scored the first-ever win for a Phase 3 study in non-obstructive hypertrophic cardiomyopathy on Friday. The post Cytokinetics Scores A First-Ever In Its Rivalry Against Bristol Myers appeared first on Investor’s Business Daily.
PayPal stock dived overnight after the Advent-Stripe consortium reportedly dropped their pursuit of the digital payments giant. The post PayPal Dives As Advent-Stripe Group Said To Drop Pursuit Of Payments Giant appeared first on Investor’s Business Daily.
Affirm stock rose amid fiscal Q4 earnings that topped estimates while fiscal 2027 guidance for a key e-commerce metric came in above views. The post Affirm Stock Climbs As Key E-Commerce Financial Metric Tops Views appeared first on Investor’s Business…
SentinelOne stock fell amid Q2 earnings and revenue that edged by estimates while October quarter sales guidance met expectations. The post SentinelOne Stock Falls As Revenue Beat, Guidance Underwhelm appeared first on Investor’s Business Daily.
Workday stock fell amid Q2 earnings that topped estimates while subscription sales guidance only met expectations. The post Workday Stock Falls As Earnings Beat, Guidance Underwhelms appeared first on Investor’s Business Daily.
Rubrik reported Q2 financial results that handily beat consensus estimates. But Rubrik stock fell amid a big run-up in 2026. The post Rubrik Earnings, Revenue Handily Beat Wall Street Targets appeared first on Investor’s Business Daily.
Elastic stock jumped Thursday after the enterprise data software company reporting fiscal first quarter results ahead of estimates. The post Elastic Stock Rockets Higher After Software Firm’s Earnings appeared first on Investor’s Business Daily.
Marvell Technology edged above expectations for its fiscal second quarter and guided higher than views for fiscal Q3. But Marvell stock fell. The post Chipmaker Marvell Edges Above Estimates But Stock Falls appeared first on Investor’s Business Daily.
CrowdStrike stock climbed amid Q2 earnings and revenue that topped estimates while the cybersecurity firm’s October quarter guidance came in above views. The post CrowdStrike Earnings Beat As AI Adoption Drives Endpoint Upgrades appeared first on Investor’s Business Daily.
Amgen and AstraZeneca’s drug, Tezspire, scored Thursday in an esophageal disease that affects an estimated 470,000 patients in the U.S. The post Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent? appeared first on Investor’s Business Daily.
